Información*
| Nombre | MARCO ANTONIO QUEZADA RAMIREZ |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | GENÓMICA HUMANA |
| Especialidad | TERAPIA |
| CVU | 268572 |
| Institución |
SIN INSTITUCIÓN
|
|---|---|
| Dependencia | NO APLICA |
| Entidad | NO APLICA |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2027 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2025
- Development of evolutionarily conserved viral integration sites as safe harbors for human gene therapy
- 2022
- Prenatal phenotype analysis and mutation identification of a fetus with meckel gruber syndrome Frontiers in Genetics
- 2021
- Poor investment and limited research positions in biomedical research: Challenges for young researchers in Mexico Health Policy and Technology
- 2020
- Curcumin downregulates Smad pathways and reduces hepatic stellate cells activation in experimental fibrosis Annals of Hepatology
- 2019
- Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways European Journal of Pharmacology
- 2018
- Annexin A1, Annexin A2, and Dyrk 1B are upregulated during GAS1-induced cell cycle arrest Journal of Cellular Physiology
- The Growth arrest specific 1 (GAS1) gene is transcriptionally regulated by NeuroD1 via two distal E-boxes Experimental Cell Research